C12N 15/8258
For the production of oral vaccines or immunoglobulins
Official title: {for the production of oral vaccines (antigens) or immunoglobulins}
C12N15/8258 (For the production of oral vaccines or immunoglobulins) appears on 278 US grants and 511 published applications in this corpus.
Search patents in C12N- Granted patents
- 278
- Published applications
- 511
- Assignees
- 228
- Inventors
- 891
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 0 | 0 |
| 1999 | 5 | 0 |
| 2000 | 11 | 0 |
| 2001 | 8 | 1 |
| 2002 | 9 | 16 |
| 2003 | 1 | 37 |
| 2004 | 7 | 23 |
| 2005 | 9 | 29 |
| 2006 | 12 | 32 |
| 2007 | 9 | 10 |
| 2008 | 10 | 25 |
| 2009 | 9 | 32 |
| 2010 | 11 | 22 |
| 2011 | 15 | 37 |
| 2012 | 14 | 18 |
| 2013 | 12 | 21 |
| 2014 | 11 | 20 |
| 2015 | 8 | 22 |
| 2016 | 9 | 16 |
| 2017 | 6 | 15 |
| 2018 | 13 | 12 |
| 2019 | 12 | 18 |
| 2020 | 8 | 20 |
| 2021 | 16 | 22 |
| 2022 | 8 | 19 |
| 2023 | 15 | 15 |
| 2024 | 13 | 12 |
| 2025 | 7 | 16 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vector for co-expressing genes of interest6 Oct 2026US 12,753,414 B2Gat Biosciences, S.L.
- Immunomodulating transgenic plants and related methods3 Mar 2026US 12,565,660 B2Agrivida, Inc.
- Plant serine proteases17 Feb 2026US 12,553,059 B2UniversitäT FüR Bodenkultur Wien
- Plant-produced mABs against chikungunya virus with enhanced effector function and efficacy11 Nov 2025US 12,466,862 B2Arizona Board of Regents on behalf of Arizona State University
- Influenza virus-like particle production in plants11 Nov 2025US 12,467,058 B2Aramis Biotechnologies Inc.
- Plant-produced mabs against chikungunya virus with enhanced effector function and efficacy8 Jan 2026US 2026/0008824 A1Arizona Board of Regents on behalf of Arizona State University
- Replicating and non-replicating vectors for recombinant protein production in plants and method of use thereof13 Nov 2025US 2025/0346915 A1Arizona Board of Regents on behalf of Arizona State University
- Production of therapeutic antibodies by the microalgae phaeodactylum tricornutum4 Sep 2025US 2025/0277228 A1Universite De Rouen Normandie
- Endogenous plant expression enhancer26 Jun 2025US 2025/0207144 A1Aramis Biotechnologies Inc.
- Plant-produced chimaeric orbivirus vlps19 Jun 2025US 2025/0197874 A1Csir
Most cited
By later US patents
- Transgenic plants expressing assembled secretory antibodies319US 5,959,177 AThe Scripps Research Institute · 1999
- Transgenic plants expressing assembled secretory antibodies273US 6,417,429 B1The Scripps Research Institute · 2002
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Oral immunization by transgenic plants68US 5,654,184 AWashington University · 1997
- Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use66US 5,202,422 AThe Scripps Research Institute · 1993